Update in ocular myasthenia gravis
10.3760/cma.j.issn.1673-4408.2014.03.016
- VernacularTitle:眼肌型重症肌无力研究进展
- Author:
Yan CHENG
- Publication Type:Journal Article
- Keywords:
Ocular myasthenia gravis;
Acetylcholine receptor;
Safety factor;
Foxp3;
CXCL13
- From:
International Journal of Pediatrics
2014;41(3):274-277
- CountryChina
- Language:Chinese
-
Abstract:
Myasthenia gravis is an autoimmune disease caused by the failure of neuromuscular transmission,which is mediated by autoantibodies against acetylcholine receptors.Ocular myasthenia is a form of myasthenia gravis in which weakened eye muscles cause double vision or drooping eyelids.It accounts for approximately 80％ of juvenile myasthenia gravis.This review focuses on the extraocular muscle susceptibility to myasthenia gravis and the management of ocular myasthenia gravis.
